Moody Aldrich Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,814
| Closed | -$1.35M | – | 207 |
|
|
2024
Q2 | $1.35M | Sell |
4,814
-310
| -6% | -$86.9K | 0.26% | 108 |
|
|
2024
Q1 | $1.37M | Sell |
5,124
-4,099
| -44% | -$1.09M | 0.23% | 115 |
|
|
2023
Q4 | $2.13M | Sell |
9,223
-4,356
| -32% | -$1.01M | 0.38% | 94 |
|
|
2023
Q3 | $1.98M | Buy |
13,579
+2,653
| +24% | +$387K | 0.38% | 89 |
|
|
2023
Q2 | $2.52M | Buy |
10,926
+3,746
| +52% | +$865K | 0.49% | 82 |
|
|
2023
Q1 | $1.74M | Buy |
+7,180
| New | +$1.74M | 0.35% | 95 |
|
|
2018
Q4 | – | Sell |
-10,467
| Closed | -$2.24M | – | 104 |
|
|
2018
Q3 | $2.24M | Buy |
10,467
+5,395
| +106% | +$1.16M | 0.65% | 75 |
|
|
2018
Q2 | $1.42M | Buy |
+5,072
| New | +$1.42M | 0.5% | 80 |
|